VCYT posts a 47% y/y Q4 earnings jump and 18.5% revenue growth, beats estimates, lifts margins and sees shares rise after ...

In a notable acquisition, ARK purchased 1,173 shares of MercadoLibre Inc. (NASDAQ:MELI) through its ARKF ETF, totaling $2,061,641. This move suggests a continued interest in the e-commerce sector, as ...

Veracyte (NASDAQ:VCYT) management said fourth-quarter results capped “another outstanding year” of execution, highlighted by ...

Q4 2025 earnings call recap: revenue +19%, Decipher/Afirma volume growth, 2026 guidance and margin outlook plus launch catalysts—read now.

Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...

SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Wednesday reported fourth-quarter profit of $41.1 million.

Veracyte, Inc. (NASDAQ:VCYT) ranks among the best innovative stocks to buy according to Wall Street analysts. On January 12, ...

(Nasdaq: VCYT), a leading cancer diagnostics company, announced today it will participate in the following investor ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Veracyte VCYT has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry’s 3.9% rise and the S&P 500 composite’s 24.4% gain. With a ...

Veracyte VCYT has consistently gained from the strength of its Afirma and Decipher tests. With Decipher expanding into metastatic and localized disease areas, the growth is likely to continue in the ...